课题基金 / 基金详情

Epigenomic regulation in skeletal muscle cells and their precursors

Epigenomic regulation in skeletal muscle cells and their precursors
骨骼肌细胞及其前体细胞的表观基因组调控
批准号:
9174484
负责人:
Brian D Dynlacht
金额:
$22.37万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-01 至 2018-03-31

项目摘要

项目成果

Brian D Dynlacht的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要
英文摘要
Project Abstract Satellite cells (SC) are muscle stem cells positioned between the basal lamina and the sarcolemma of muscle fibers, and they serve as a pool to regenerate muscle tissue that has been damaged. Whereas embryonic stem (ES) cells have been extensively characterized at the transcriptional and epigenetic levels, our understanding of satellite cells is rudimentary. Although SC are essential for muscle regeneration, they have proven refractory to characterization owing to a number of technical impediments, including their paucity in muscle tissue, the inability of ES cells to differentiate into skeletal muscle, and the inability of SC to maintain “stemness” in culture. Recently, we have begun characterizing a novel satellite cell model—iPax7 cells--in which the master regulator of satellite cell identity, Pax7, is inducibly expressed in ES cells. iPax7 cells have been shown to repopulate the satellite cell niche in animals, but they have not been characterized at the molecular or genomic level. Our goals are as follows. First, we will more deeply characterize the novel iPax7 model for satellite cells. Second, we will for the first time attempt to obtain a satellite cell-specific gene expression signature. We will identify markers of SC, which will be of further value for understanding and characterizing satellite cells and other myogenic precursors. Third, we will unravel how Pax7, a master regulator required for specification and maintenance of SC identity, assembles key regulatory elements. This will enable us to devise a gene regulatory network or “blueprint” for satellite cells, allowing us to understand how Pax7 controls expression of other transcription factors that specify stem cell identity. We will leverage our recently acquired epigenetic data and Pax7 ChIP-seq data, as well as our rich data set mapping the genomic landscape of myoblasts and myotubes, to pursue two Specific Aims. In Aim 1, we will compare iPax7 cells with muscle-derived satellite cells and ES cells using genome-wide epigenetic and transcriptome-level comparisons. These studies will allow us to identify satellite cell-specific signatures. We will test the hypothesis that a set of transcription factors collaborates with Pax7 to dictate satellite cell identity. In Aim 2, we will examine the role of Pax7 in modulating the epigenomic landscape of myogenic precursors and SC by dissecting its role at regulatory elements. Our studies will lay important groundwork for a comprehensive understanding of the transcriptional networks and epigenomic changes that accompany the restriction from pluripotency to skeletal muscle identity. Additionally, these studies may reveal essential mechanistic roles for Pax7 in satellite cell maintenance, a poorly understood area. Understanding and utilizing these myogenic precursors, which can be manipulated at will, may prove invaluable in a clinical setting, opening novel avenues to improve their regenerative capacity and suggesting possible therapeutic opportunities for treatment of muscle wasting and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tubulin modifications and cytoskeletal alterations in aging
Exploring networks underlying muscle stem cell identity - Resubmission - 1
Exploring networks underlying muscle stem cell identity - Resubmission - 1
Exploring networks underlying muscle stem cell identity - Resubmission - 1
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: